Probable Early-Onset Alzheimer’s Disease in an Apolipoprotein E2 Homozygote

scientific article published on October 23, 2010

Probable Early-Onset Alzheimer’s Disease in an Apolipoprotein E2 Homozygote is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1159/000320589
P953full work available at URLhttps://europepmc.org/articles/PMC2992638
https://europepmc.org/articles/PMC2992638?pdf=render
https://www.karger.com/Article/Pdf/320589
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20975270/?tool=EBI
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20975270/pdf/?tool=EBI
https://doi.org/10.1159/000320589
P932PMC publication ID2992638
P698PubMed publication ID20975270
P5875ResearchGate publication ID47544702

P2093author name stringLauren Cole
Carolyn Liebsack
Sandra Jacobson
Christine Belden
Marwan N. Sabbagh
Camryn Berk
Cornelia Reninger
Kent Myers
P2860cites workThe importance of neuritic plaques and tangles to the development and evolution of ADQ22241659
Apolipoprotein E and Alzheimer diseaseQ24563061
“Mini-mental state”Q25938989
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer diseaseQ28238269
Apolipoprotein E: cholesterol transport protein with expanding role in cell biologyQ28294791
A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's diseaseQ34159318
Possible Alzheimer's disease in an apolipoprotein E2 homozygoteQ34198068
Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid studyQ34287865
The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validityQ34482688
Dissociation of neuropathologic findings and cognition: case report of an apolipoprotein E epsilon2/epsilon2 genotype.Q36042420
CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatmentQ36252166
Subcortical infarcts, Alzheimer's disease pathology, and memory function in older personsQ38397294
Quantitative and qualitative analyses of clock drawings in Alzheimer's and Huntington's diseaseQ38474560
Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptidesQ41172424
Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcomeQ43788870
Amyloid beta(1-42) and phosphorylated tau in CSF as markers for early-onset Alzheimer diseaseQ47621803
Visual perception of line direction in patients with unilateral brain diseaseQ48436468
Premorbid effects of APOE on synaptic proteins in human temporal neocortexQ48833095
Latent sensory aphasia in hemisphere-damaged patients: an experimental study with the Token Test.Q51225950
The token test: A sensitive test to detect receptive disturbances in aphasics.Q51291128
Validation of a short Orientation-Memory-Concentration Test of cognitive impairment.Q52215816
Apolipoprotein E-epsilon 2 and Alzheimer's disease: genotype influences pathologic phenotype.Q53216216
Functional assessment staging (FAST)Q57306313
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectAlzheimer's diseaseQ11081
early-onset Alzheimer's diseaseQ5326566
P304page(s)387-391
P577publication date2010-10-23
P1433published inDementia and Geriatric Cognitive DisordersQ15749436
P1476titleProbable early-onset Alzheimer's disease in an apolipoprotein E2 homozygote
Probable Early-Onset Alzheimer’s Disease in an Apolipoprotein E2 Homozygote
P478volume30

Reverse relations

Q88121156Pathologically Confirmed Alzheimer's Disease in APOE ɛ2 Homozygotes is Rare but Does Occurcites workP2860